|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-3.10/6.97
|
企業價值
128.49B
|
資產負債 |
每股賬面淨值
8.13
|
現金流量 |
現金流量率
0.15
|
損益表 |
收益
45.01B
|
每股收益
22.17
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/16 16:15 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group. |